Activating transcription factor 7-interacting protein 1 (ATF7IP)

Activating transcription factor 7-interacting protein 1 (ATF7IP) is a multifunctional nuclear protein that plays a central role in heterochromatin formation and epigenetic gene silencing[1][3]. ATF7IP interacts with chromatin-associated proteins such as SETDB1, stabilizing this histone methyltransferase and promoting H3K9 trimethylation, which is crucial for forming transcriptionally repressive heterochromatin[1][2][3][7]. It also bridges DNA methylation and repressive histone marks through partnerships with methyl-CpG–binding proteins like MBD1[1][3]. ATF7IP regulates telomerase gene transcription (TERT) via Sp1-dependent processes in cancer cells, linking its chromatin regulatory functions to cellular immortalization and tumorigenesis[1][3]. Additional roles include facilitating central immune tolerance by partnering with the transcription factor Aire and involvement in neurodegeneration and other chromatin-linked diseases[1]. ATF7IP is not classified as a receptor, enzyme, ion channel, or transporter, but as a chromatin regulator and transcriptional modulator, making it a potential therapeutic target in epigenetic and chromatin-related diseases such as cancer and immune disorders, though no drugs directly target ATF7IP to date[1][3][7].

Other names

MCAF1ATF7IP1MCAFATF-IPhAMFLJ10688p621AMATF-interacting proteinATF7-interacting proteinATFa-associated modulatorMBD1-containing chromatin-associated factor 1P621

Drugs targeting ATF7IP would theoretically act by disrupting its interactions with SETDB1, MBD1, or the chromatin silencing machinery, impacting histone methylation and heterochromatin formation[2][3].